•
Sep 30, 2022

3M Q3 2022 Earnings Report

3M reported mixed Q3 2022 results, with strong GAAP EPS but sales impacted by currency and divestitures.

Key Takeaways

3M reported Q3 2022 results with GAAP earnings per share of $6.77 and adjusted earnings per share of $2.69. Sales were $8.6 billion, down 4 percent year-on-year, impacted by divestitures and foreign currency translation. Organic sales growth was 2 percent, including a headwind from declining respirator demand. The company updated its full-year sales and earnings expectations to reflect the strengthening U.S. dollar and the uncertain macroeconomic environment.

GAAP earnings per share were $6.77, and adjusted earnings per share was $2.69.

Sales reached $8.6 billion, a 4% decrease year-over-year due to divestitures and currency translation.

Organic sales grew by 2%, but were impacted by a decline in disposable respirator demand.

3M updated its full-year sales and earnings expectations to reflect the strengthening U.S. dollar and uncertain macroeconomic conditions.

Total Revenue
$8.62B
Previous year: $8.94B
-3.6%
EPS
$2.69
Previous year: $2.45
+9.8%
Organic Revenue Growth
2%
Previous year: 6.3%
-68.3%
Gross Profit
$3.89B
Previous year: $4.09B
-4.8%
Cash and Equivalents
$3.4B
Previous year: $4.88B
-30.2%
Free Cash Flow
$1.1B
Previous year: $1.53B
-28.4%
Total Assets
$46.2B
Previous year: $48.3B
-4.4%

3M

3M

3M Revenue by Segment

Forward Guidance

3M updated its full-year sales and earnings expectations to reflect the continued strengthening of the U.S. dollar and the uncertain macroeconomic environment.

Positive Outlook

  • Focus on investments for growth, productivity, and sustainability.
  • Active portfolio management, including the divestiture of the food safety business.
  • Plans to spin off the Health Care business into a separate public company.
  • Expects operating cash flow of $6.8 to $7.4 billion.
  • Anticipates adjusted free cash flow conversion of 85% to 95%.

Challenges Ahead

  • Total sales growth is expected to be -3.5% to -3.0%.
  • Organic sales growth is projected to be 1.5% to 2.0%.
  • Acquisition and divestiture sales growth is estimated at -0.5%.
  • Foreign currency translation impact on sales is expected to be -4.5%.
  • Adjusted earnings per share are forecasted to be $10.10 to $10.35.

Revenue & Expenses

Visualization of income flow from segment revenue to net income